Exagen inc. to announce fourth quarter and full-year 2024 financial results on march 11, 2025

Carlsbad, calif., feb. 25, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing, will release financial results for the quarter and year ended december 31, 2024, before the market opens on tuesday, march 11, 2025. john aballi, exagen's president and chief executive officer, and jeff black, chief financial officer, will host a conference call to review the company's results at 8:30 am et (5:30 am pt).
XGN Ratings Summary
XGN Quant Ranking